Richard Ashley - Abbott Laboratories Insider

ABTT34 -- Brazil Stock  

BRL 70.93  0.16  0.23%

  EVP
Mr. Richard W. Ashley is Executive Vice President Corporationrationrate Development of the Company. His responsibilities include various aspects of corporate strategic planning and business development. Ashley was appointed to his current position in February of 2004. Prior to joining Abbott he was a Senior Director at McKinsey and Company a former Managing Partner of the firm Chicago office and Head of the firm Global Leadership and Organization practice. During his 31 years with McKinsey Ashley consulted with clients in healthcare energy and industrial manufacturing industries across a wide range of business and organizational issues
Age: 71  EVP Since 2004      
224-667-6100  http://www.abbott.com
Ashley is a member of the Executive Committee of the board of directors of Junior Achievement of Chicago and a former member of the Civic Committee of the Commercial Club of Chicago. He is also a member of the American Bar Association and the Wisconsin Bar Association. He earned a Bachelor Degree in Political Science and Master degree in Business Administration from Northwestern University. He also holds a Juris Doctorate from the University of Wisconsin Law School.

Richard Ashley Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 3.17 % which means that it generated profit of $3.17 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 2.63 % meaning that it generated $2.63 on every $100 dollars invested by stockholders.
The company has accumulated 20.9 B in total debt with debt to equity ratio (D/E) of 67.9 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Abbott Laboratories has Current Ratio of 1.55 which is within standard range for the sector.

Entity Summary

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. The company was founded in 1888 and is headquartered in Abbott Park, Illinois. Abbott Laboratories operates under Medical Devices classification in Brazil and traded on Sao Paolo Stock Exchange. It employs 99000 people.Abbott Laboratories (ABTT34) is traded on Sao Paolo Stock Exchange in Brazil. It is located in 100 Abbott Park Road and employs 99,000 people.

Abbott Laboratories Leadership Team

Scott White, Senior Vice President - International Nutrition
Samuel Scott, Independent Director
Deepak Nath, Senior Vice President - Abbott Vascular
Jaime Contreras, Senior Vice President - Core Laboratory Diagnostics, Commercial Operations
Roger Bird, Senior Vice President - U.S. Nutrition
Nancy McKinstry, Independent Director
Heather Mason, Senior Vice President - Abbott Diabetes Care
James Farrell, Independent Director
Phebe Novakovic, Independent Director
JeanYves Pavee, Senior Vice President - Established Pharmaceuticals, Developed Markets
Andrew Lane, Senior Vice President - Established Pharmaceuticals, Emerging Markets
Roxanne Austin, Independent Director
Georges Vos, Senior Vice President - Established Pharmaceuticals, Emerging Markets
Stephen Fussell, Senior Vice President - Human Resources
Thomas Freyman, Executive VP of Fin. and Admin.
Sally Blount, Independent Director
Daniel Starks, Independent Director
Thomas Frinzi, Senior Vice President - Abbott Medical Optics
Eric Fain, Senior Vice President Group President - Cardiovascular and Neuromodulation
John Capek, Executive VP of Ventures
Robert Alpern, Independent Director
Murthy Simhambhatla, Senior Vice President - Abbott Medical Optics
Miles White, Chairman, CEO and Chairman of Executive Committee
Robert Ford, Senior Vice President Diabetes Care.
Glenn Tilton, Independent Director
Richard Ashley, Executive VP of Corporate Devel.
Michael Rousseau, President - Cardiovascular and Neuromodulation
Edward Liddy, Independent Director
Hubert Allen, Executive VP, General Counsel and Secretary
Charles Foltz, Senior Vice President - Abbott Vascular
Brian Yoor, CFO and Sr. VP of Fin.
John Stratton, Director
Joseph Manning, Senior Vice President - Abbott Nutrition International
Jared Watkin, Senior Vice President - Diabetes Care
William Osborn, Independent Director
Brian Blaser, Executive VP of Diagnostic Products
Michael Warmuth, Executive Vice President - Established Pharmaceuticals
Robert Funck, Vice President Controller
Daniel Salvadori, Senior Vice President Established Pharmaceuticals, Latin America.

Stock Performance Indicators

Did you try this?

Run Money Managers Now

   

Money Managers

Screen money managers from public funds and ETFs managed around the world
All  Next Launch Money Managers

Abbott Laboratories Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Abbott Laboratories and Magnesita Refratrios. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Search macroaxis.com